Human group 3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation

European Journal of Immunology

Volumn 45, Issue 8, 2015, Pages 2335-2342

  Ahn, Yong Oon ^a,b   Weeres, Matthew A ^a   Neulen, Marie Luise ^a   Choi, Jahyang ^b   Kang, Seong Ho ^b   Heo, Dae Seog ^b   Bergerson, Rachel ^a   Blazar, Bruce R ^a   Miller, Jeffrey S ^a   Verneris, Michael R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

DR3; Human; IL 22; ILC3; TL1A

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CD56 ANTIGEN; DEATH RECEPTOR 3; EOMESODERMIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE LIGAND 1A; UNCLASSIFIED DRUG; IL1B PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; IL23A PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 23P19; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; TNFRSF25 PROTEIN, HUMAN; TNFSF15 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ANIMAL CELL; ARTICLE; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY DISEASE; LYMPHOID CELL; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; UPREGULATION; CELL CULTURE; CLASSIFICATION; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE;

CELL PROLIFERATION; CELLS, CULTURED; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1BETA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKIN-8; INTERLEUKINS; LYMPHOCYTES; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; UP-REGULATION;

EID: 84938991556     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445213     Document Type: Article

References (31)

1. Bamias, G., Mishina, M., Nyce, M., Ross, W. G., Kollias, G., Rivera-Nieves, J., Pizarro, T. T. and Cominelli, F., Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. U S A 2006. 103: 8441-8446.
2. Longman, R. S., Diehl, G. E., Victorio, D. A., Huh, J. R., Galan, C., Miraldi, E. R. and Swaminath, A., CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 2014. 211: 1571-1583.
3. Prehn, J. L., Thomas, L. S., Landers, C. J., Yu, Q. T., Michelsen, K. S. and Targan, S. R., The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J. Immunol. 2007. 178: 4033-4038.
4. Migone, T. S., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B. and Hong, J. S., TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002. 16: 479-492.
5. Twohig, J. P., Marsden, M., Cuff, S. M., Ferdinand, J. R., Gallimore, A. M., Perks, W. V. and Al-Shamkhani, A., The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4(+) and CD8(+) T-cell immunity. FASEB J. 2012. 26: 3575-3586.
6. Papadakis, K. A., Prehn, J. L., Landers, C., Han, Q., Luo, X., Cha, S. C., Wei, P. and Targan, S. R., TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J. Immunol. 2004. 172: 7002-7007.
7. Heidemann, S. C., Chavez, V., Landers, C. J., Kucharzik, T., Prehn, J. L. and Targan, S. R., TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets. J. Clin. Immunol. 2010. 30: 531-538.
8. Schreiber, T. H., Wolf, D., Tsai, M. S., Chirinos, J., Deyev, V. V., Gonzalez, L. and Malek, T. R., Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 2010. 120: 3629-3640.
9. Wolf, D., Schreiber, T. H., Tryphonopoulos, P., Li, S., Tzakis, A. G., Ruiz, P. and Podack, E. R., Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival. Transplantation 2012. 94: 569-574.
10. Fang, L., Adkins, B., Deyev, V. and Podack, E. R., Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 2008. 205: 1037-1048.
11. Meylan, F., Song, Y. J., Fuss, I., Villarreal, S., Kahle, E., Malm, I. J. and Acharya, K., The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol. 2011. 4: 172-185.
12. Taraban, V. Y., Slebioda, T. J., Willoughby, J. E., Buchan, S. L., James, S., Sheth, B. and Smyth, N. R., Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol.2011. 4: 186-196.
13. Takedatsu, H., Michelsen, K. S., Wei, B., Landers, C. J., Thomas, L. S., Dhall, D., Braun, J. and Targan, S. R., TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008. 135: 552-567.
14. Pappu, B. P., Borodovsky, A., Zheng, T. S., Yang, X., Wu, P., Dong, X. and Weng, S., TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 2008. 205: 1049-1062.
15. Meylan, F., Davidson, T. S., Kahle, E., Kinder, M., Acharya, K., Jankovic, D. and Bundoc, V., The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 2008. 29: 79-89.
16. Jones, G. W., Stumhofer, J. S., Foster, T., Twohig, J. P., Hertzog, P., Topley, N. and Williams, A. S., Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 2011. 25: 409-419.
17. Spits, H. and Di Santo, J. P., The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011. 12: 21-27.
18. Spits, H. and Cupedo, T., Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 2012. 30: 647-675.
19. Eberl, G., Marmon, S., Sunshine, M. J., Rennert, P. D., Choi, Y. and Littman, D. R., An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 2004. 5: 64-73.
20. Scandella, E., Bolinger, B., Lattmann, E., Miller, S., Favre, S., Littman, D. R. and Finke, D., Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 2008. 9: 667-675.
21. Tang, Q., Ahn, Y. O., Southern, P., Blazar, B. R., Miller, J. S. and Verneris, M. R., Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue. Blood. 2011. 117: 4052-4055.
22. Hughes, T., Becknell, B., McClory, S., Briercheck, E., Freud, A. G., Zhang, X. and Mao, H., Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood. 2009. 113: 4008-4010.
23. Ahn, Y. O., Blazar, B. R., Miller, J. S. and Verneris, M. R., Lineage relationships of human interleukin-22-producing CD56+ RORgammat+ innate lymphoid cells and conventional natural killer cells. Blood. 2013. 121: 2234-2243.
24. Meylan, F., Hawley, E. T., Barron, L., Barlow, J. L., Penumetcha, P., Pelletier, M. and Sciume, G., The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol. 2013.
25. Yu, X., Pappu, R., Ramirez-Carrozzi, V., Ota, N., Caplazi, P., Zhang, J. and Yan, D., TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol. 2014. 7: 730-740.
26. Kim, M. Y., Toellner, K. M., White, A., McConnell, F. M., Gaspal, F. M., Parnell, S. M. and Jenkinson, E., Neonatal and adult CD4+ CD3- cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 2006. 177: 3074-3081.
27. Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, II, Littman, D. R., Maloy, K. J. and Powrie, F., Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010. 464: 1371-1375.
28. Hughes, T., Becknell, B., Freud, A. G., McClory, S., Briercheck, E., Yu, J. and Mao, C., Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010. 32: 803-814.
29. Cella, M., Otero, K. and Colonna, M., Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. U S A 2010. 107: 10961-10966.
30. Bernink, J. H., Peters, C. P., Munneke, M., te Velde, A. A., Meijer, S. L., Weijer, K. and Hreggvidsdottir, H. S., Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 2013. 14: 221-229.
31. Hazenberg, M. D. and Spits, H., Human innate lymphoid cells. Blood 2014. 124: 700-709.